Skip to main content
Fig. 2 | Journal of Translational Medicine

Fig. 2

From: The POR rs10954732 polymorphism decreases susceptibility to hepatocellular carcinoma and hepsin as a prognostic biomarker correlated with immune infiltration based on proteomics

Fig. 2

POR rs10954732 polymorphisms related to decreased HCC susceptibility and increased OS of HCC patients as well as enzyme activity for CYP2E1 in healthy subjects and HCC patients. a Univariate logistic regression analysis of the association between rs10954732 polymorphisms and the risk of HCC. b Kaplan–Meier curve for overall survival (OS) of HCC patients between the GG genotype and GA + AA genotypes in HCC patients. Biochemical data (c) and CYP2E1 activity (d) in subjects between GG genotype and A allele carriers in healthy subjects and HCC patients. A allele carriers, GA + AA genotypes. Normal, healthy subjects. HCC, hepatocellular carcinoma. AST transaminase, ALT alanine aminotransferase, Vmax maximum reaction velocity, CLint intrinsic clearance. Data are expressed as mean ± SEM, P value was calculated by Mann–Whitney U test

Back to article page